ClinicalTrials.gov: Other terms: heart disease | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: heart disease | First posted in the last 14 days
July 17, 2026
Conditions: Tinnitus
Interventions: Procedure: True Foot Reflexology; Procedure: Sham Foot Reflexology; Device: True ta-VNS; Device: Sham ta-VNS; Procedure: True Auricular Acupressure; Procedure: Sham Auricular Acupressure; Other: Usual Care
Sponsors: Tzu Chi University; Buddhist Tzu Chi Medical Foundation
Recruiting
July 17, 2026
Conditions: Coronary Artery Disease
Interventions: Other: Cardiopulmonary Bypass Duration; Other: Aortic Cross-Clamp Duration
Sponsors: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not yet recruiting
July 17, 2026
Conditions: Metabolic Syndrome (MetS)
Interventions: Behavioral: Time-restricted eating; Behavioral: Physical Activity; Behavioral: Low Glycemic Load diet; Behavioral: Sleep hygiene
Sponsors: National University Health System, Singapore
Not yet recruiting
July 17, 2026
Conditions: Atrial Fibrillation (AF); Chronic Lymphocytic Leukemia; Waldenstrom Macroglobulinemia; Mantle Cell Lymphoma; Marginal Zone Lymphoma
Sponsors: Tina Baykaner
Not yet recruiting
July 17, 2026
Conditions: Aortic Valve Stenosis; Transcatheter Aortic Valve Replacement (TAVR)
Interventions: Procedure: Transcatheter Aortic Valve Replacement
Sponsors: Eunpyeong St. Mary's Hospital; RCF@ICPS; Kokura Memorial Hospital
Recruiting
July 17, 2026
Conditions: Heart Failure
Interventions: Diagnostic Test: NT-proBNP testing; Device: Cardiac Point-of-Care Ultrasound (POCUS); Other: standard of care
Sponsors: Universidade do Porto
Recruiting
July 17, 2026
Conditions: Functional Neurological Disorder; Motor Symptoms
Interventions: Device: Vagial Nerve Stimulation (VNS) active stimulation; Device: Vagial Nerve Stimulation (VNS) sham stimulation
Sponsors: University of Fribourg; Hôpital Cantonal de Fribourg
Not yet recruiting
July 17, 2026
Conditions: HIV; Hypertension; Cardiovascular Disease Prevention
Interventions: Behavioral: INTEGRATE-RX
Sponsors: Temple University; National Heart, Lung, and Blood Institute (NHLBI); Purdue University; Brown University; Duke University; NYU Langone Health; Moi Teaching and Referral Hospital
Not yet recruiting
July 17, 2026
Conditions: Coronary Artery Disease (CAD); Chronic Coronary Syndrome; Left Main Coronary Artery Disease; Coronary Bifurcation Lesion
Interventions: Procedure: IVUS-Guided LM PCI; Procedure: "Trained Eye" (Angiography-Guided) LM PCI
Sponsors: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Recruiting
July 17, 2026
Conditions: Arterial Hypertension
Interventions: Behavioral: Mindfulness-Based Living Course (MBLC); Behavioral: Forest therapy
Sponsors: University of Rijeka
Completed
July 17, 2026
Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate hydrochloride extended-release capsules
Sponsors: Dar Clinical Research Inc.
Not yet recruiting
July 17, 2026
Conditions: Chronic Kidney Disease, Stage 5; Chronic Kidney Disease, Stage 4; Chronic Kidney Disease, Stage 3
Interventions: Other: Retrospective data collection; Other: Prospective data collection; Other: External validation
Sponsors: Huashan Hospital; Jingan District Central Hospital of Shanghai (Jingan Branch of Huashan Hospital Affiliated to Fudan University); Fudan University Affiliated Shanghai Fifth People's Hospital Hospital
Not yet recruiting
July 17, 2026
Conditions: Left Ventricular Thrombus
Interventions: Drug: Apixaban; Drug: Warfarin
Sponsors: University of Arizona
Recruiting
July 17, 2026
Conditions: Cardiovascular Disease
Interventions: Combination Product: Placebo; Combination Product: Adjuvanted RZV vaccine; Biological: Adjuvanted RSVPreF3 vaccine
Sponsors: GlaxoSmithKline
Not yet recruiting
July 17, 2026
Conditions: Seasonal Allergic Rhinitis
Interventions: Drug: Rupatifen Fumarate Capsules; Drug: Rupatadine Fumarate Tablets; Drug: Rupatifen Fumarate Capsules Placebo; Drug: Rupatadine Fumarate Tablets Placebo
Sponsors: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
Not yet recruiting
July 17, 2026
Conditions: Infection, Human Immunodeficiency Virus
Interventions: Drug: ACC017+FTC/TAF; Drug: DTG+FTC/TAF
Sponsors: Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Recruiting
July 17, 2026
Conditions: Healthy Controls
Interventions: Drug: Psilocybin (low dose) or Placebo
Sponsors: Diamond Therapeutics Inc.; BioPharma Services Inc.
Completed
July 17, 2026
Conditions: Obesity (BMI>30); Metabolically Healthy Obesity; Metabolically Unhealty Obese
Interventions: Behavioral: Physical Training of 16 weeks
Sponsors: University of Sao Paulo
Not yet recruiting
July 17, 2026
Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: Drug: Lumacaftor 200 MG; Drug: Placebo
Sponsors: Qanatpharma AG; Qanatpharma Canada LTD
Recruiting
July 17, 2026
Conditions: Infection, Human Immunodeficiency Virus
Interventions: Drug: ACC017; Drug: Placebo
Sponsors: Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Active, not recruiting
July 17, 2026
Conditions: Obesity & Overweight; Insulin Resistance; Inflamation
Interventions: Behavioral: Carbohydrate-last eating; Behavioral: Sequential training
Sponsors: Peking University
Not yet recruiting
July 17, 2026
Conditions: Healthy
Interventions: Drug: 11C-ARMI
Sponsors: National Institute of Mental Health (NIMH)
Recruiting
July 17, 2026
Conditions: Interstitial Lung Diseases
Interventions: Device: Inspiratory Muscle Training; Behavioral: Peripheral Muscle Strengthening Exercises; Behavioral: Aerobic Exercise Training (Cycle Ergometer); Device: Whole-Body Vibration Training
Sponsors: Istinye University
Completed
July 17, 2026
Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease; Mucosal Ulcerations
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
July 17, 2026
Conditions: Advanced Left Ventricular Heart Failure
Interventions: Device: Corheart 6 LVAS
Sponsors: Shenzhen Core Medical Technology CO.,LTD.
Not yet recruiting
July 17, 2026
Conditions: Aspergillos; Mucormye; Dimorphic; Other Molds; Non-Aspergillos; Non-Mucormycosis
Interventions: Drug: [18F]-Fluorocellobiose ([18F]FCB)
Sponsors: National Institutes of Health Clinical Center (CC)
Recruiting
July 17, 2026
Conditions: Coronary Artery Disease; Chronic Coronary Syndrome
Interventions: Diagnostic Test: stress SPECT/CT; Diagnostic Test: rest SPECT/CT
Sponsors: Centre Hospitalier Régional d'Orléans
Not yet recruiting
July 17, 2026
Conditions: Recurrent Prostate Cancer; Prostate Cancer
Interventions: Drug: N-803; Drug: ETBX-71 Vaccine; Radiation: 18F-DCFPyL
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
July 16, 2026
Conditions: Post-tuberculosis Lung Disease; Tuberculosis (TB)
Interventions: Behavioral: Individualized Pulmonary Rehabilitation Program; Other: Standard Post-Tuberculosis Care
Sponsors: Filantropia Hospital
Not yet recruiting
July 16, 2026
Conditions: Emotion Regulation Disorders
Interventions: Device: Virtual Reality Exposure Therapy
Sponsors: Psychiatric University Hospital, Zurich
Not yet recruiting
July 16, 2026
Conditions: Neurofibromatosis Type 2; NF2; NF2-related Schwannomatosis; Meningioma; Ependymoma; Vestibular Schwannoma
Interventions: Drug: Selumetinib
Sponsors: Beijing Tiantan Hospital; AstraZeneca
Not yet recruiting
July 16, 2026
Conditions: Atrial Fibrillation (AF); Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Sponsors: Ewha Womans University Mokdong Hospital
Not yet recruiting
July 16, 2026
Conditions: Cardiac Disease; Depression and Quality of Life; Cardiac Distress; Myocardial Infarction; Psychological Distress; Anxiety
Interventions: Behavioral: Remote-delivery Balance in Everyday Life (rBEL) Program for Myocardial Infarction Patients Younger Than 55 Years With Cardiac Distress
Sponsors: Uppsala University
Not yet recruiting
July 16, 2026
Conditions: Coronary Artery Disease
Interventions: Device: AI-Powered Active Noise-Cancelling Headphones (Sony WH-1000XM6)
Sponsors: Qilu Hospital of Shandong University
Completed
July 16, 2026
Conditions: Long COVID; Post-COVID Conditions; Fatigue; Cognitive Dysfunction
Interventions: Device: Transcranial Direct Current Stimulation
Sponsors: University of Las Palmas de Gran Canaria; Fundación Canaria Instituto de Investigación Sanitaria de Canarias; Canary Islands Health Service
Not yet recruiting
July 16, 2026
Conditions: Resistant Hypertension; Medication Adherence; Autonomic Nervous System
Interventions: Diagnostic Test: Heart rate variability recording (Polar H10) ·; Diagnostic Test: Therapeutic drug monitoring (antihypertensive drug levels); Other: Questionnaires (MARS-CZ, PHQ-9, SF-36, IPAQ)
Sponsors: Nemocnice AGEL Trinec-Podlesi a.s.; Masaryk University
Not yet recruiting
July 16, 2026
Conditions: Ingrown Toenail; Virtual Reality
Interventions: Other: Virtual Reality (VR)
Sponsors: Ankara City Hospital Bilkent
Not yet recruiting
July 16, 2026
Conditions: Polycystic Ovary Syndrome
Interventions: Other: Intermittent fasting diet group; Other: High intensity interval training
Sponsors: Cairo University
Not yet recruiting
July 16, 2026
Conditions: Light Chain (AL) Amyloidosis
Interventions: Biological: NXC-201; Drug: Dara-CyBorD
Sponsors: Nexcella Inc.; Immix Biopharma, Inc.
Not yet recruiting
July 16, 2026
Conditions: Sepsis
Interventions: Other: Not applicable- observational study
Sponsors: Beijing Chao Yang Hospital; The People's Hospital of Hebei Province; Tianjin First Central Hospital; Second Hospital of Shanxi Medical University; Beijing Obstetrics and Gynecology Hospital; Affiliated Hospital of Hebei University; Hebei Provincial Hospital of Traditional Chinese Medicine; Hangzhou Hospital of Traditional Chinese Medicine; Baoding First Central Hospital; The Hospital of Shunyi District Beijing; Cangzhou Central Hospital; Hengshui People's Hospital; General Hospital of Taiyuan Iron & Steel Company; Changzhi People's Hospital; Jincheng People's Hospital; Xinxiang Central Hospital; Luohe Central Hospital; Inner Mongolia Baogang Hospital; Tianjin Medical University Cancer Institute and Hospital
Enrolling by invitation
July 16, 2026
Conditions: COPD
Interventions: Other: Moderate intensity continuous aerobic exercise (MICE); Other: High-intensity interval aerobic exercise (HIIE)
Sponsors: George Papanicolaou Hospital
Recruiting
July 16, 2026
Conditions: Perimenopausal Insomnia
Interventions: Other: Auricular Acupressure; Other: sham Auricular Acupressure
Sponsors: The First Affiliated Hospital of Zhejiang Chinese Medical University
Not yet recruiting
July 16, 2026
Conditions: Chronic Hypoparathyroidism
Interventions: Diagnostic Test: Arterial stiffness in the aorta by measurement of pulse wave velocity; Diagnostic Test: Central blood pressures and reflected waves in the aorta; Diagnostic Test: Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques; Diagnostic Test: Imaging of the sublingual microcirculation (GlycoCheck system); Diagnostic Test: Ankle-brachial index (ABI); Diagnostic Test: Fundoscopy; Diagnostic Test: Cardiac Ultrasonography Study; Diagnostic Test: Local shear stress in brachial and carotid artery; Diagnostic Test: Peripheral and aortic office and ambulatory blood pressure; Diagnostic Test: Circulating levels of myocardial biomarkers; Diagnostic Test: Evaluation of Calcium metabolism
Sponsors: National and Kapodistrian University of Athens; 251 Hellenic Air Force & VA General Hospital; Alexandra Hospital, Athens, Greece; G.Gennimatas General Hospital; Laikο General Hospital, Athens; Korgialenio-Benakio Red Cross Hospital; AHEPA University Hospital; 424 General Military Hospital; Hippocration General Hospital; KAT Hospital of Athens; Evaggelismos Hospital, Greece
Active, not recruiting
July 16, 2026
Conditions: Myelofibrosis
Interventions: Drug: TQ05105 tablets; Drug: Placebo tablets; Drug: Moxifloxacin Hydrochloride Tablets
Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
July 16, 2026
Conditions: Cardiac Arrest; Anxiety Depression; Family Support
Interventions: Other: Education Intervention
Sponsors: Children's Hospital of Philadelphia
Recruiting
July 16, 2026
Conditions: Systemic Juvenile Idiopathic Arthritis (sJIA); Adult Onset Still's Disease (AOSD)
Interventions: Drug: Anakinra (Kineret®)
Sponsors: Swedish Orphan Biovitrum; Tigermed Consulting Co., Ltd
Withdrawn
July 16, 2026
Conditions: GERD, Acid Reflux, Treatment
Interventions: Diagnostic Test: PCAB-test guided
Sponsors: Mahidol University
Enrolling by invitation
July 16, 2026
Conditions: Disorders of Consciousness Due to Severe Brain Injury; Disorders of Consciousness
Interventions: Device: Overground Robotic Exoskeleton (ORE)
Sponsors: Spaulding Rehabilitation Hospital
Not yet recruiting
July 16, 2026
Conditions: Obesity, Morbid
Interventions: Procedure: Sleeve Gastrectomy
Sponsors: Laval University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting
July 16, 2026
Conditions: Sleep Disorders
Interventions: Drug: MMH-450
Sponsors: Materia Medica Holding
Completed
July 16, 2026
Conditions: Aging; Cellular Senescence; Biomarkers / Blood; Age-Related Diseases; Frailty
Sponsors: Fundacion Miguel Servet; Gobierno de Navarra
Recruiting
July 16, 2026
Conditions: Arrhythmogenic Cardiomyopathy (AC, ARVD/C)
Interventions: Behavioral: Cardiac Rehabilitation Programme
Sponsors: Juan Jiménez Jáimez; Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Not yet recruiting
July 16, 2026
Conditions: Heart Failure - NYHA II - IV; Mitral Regurgitation Functional
Interventions: Other: Guideline-Directed Medical Therapy (GDMT); Procedure: Mitral valve TEER
Sponsors: Jena University Hospital
Not yet recruiting
July 16, 2026
Conditions: Heart Failure; Anemia
Interventions: Drug: Oral iron supplementation
Sponsors: Universidade do Porto
Completed
July 16, 2026
Conditions: Schistosomiasis
Interventions: Procedure: right heart catheterization for measure pulmonary artery pressure
Sponsors: Sohag University
Not yet recruiting
July 16, 2026
Conditions: Obsessive-Compulsive Disorder
Interventions: Behavioral: Digital Mindfulness-Based Therapy; Drug: Routine Pharmacological Treatment
Sponsors: Central South University; Second Xiangya Hospital of Central South University
Recruiting
July 16, 2026
Conditions: Knee Osteoarthritis; Knee Osteoarthritis (Knee OA)
Interventions: Other: Inspiratory muscle training; Other: Sham inspiratory muscle training
Sponsors: The Hong Kong Polytechnic University; Zunyi Medical College
Not yet recruiting
July 16, 2026
Conditions: Pediatric; Adenotonsillectomy
Interventions: Other: AI-Generated Maternal Voice Storytelling; Other: Relaxing Instrumental Music; Drug: midazolam premedication; Procedure: Standard General Anesthesia Care; Device: Headphones
Sponsors: Adiyaman University Research Hospital
Not yet recruiting
July 16, 2026
Conditions: Myocardial Infarction (MI); Cardiac Rehabilitation
Interventions: Behavioral: Avatar-based discharge education application; Behavioral: Standard discharge education
Sponsors: Suleyman Demirel University
Completed
July 16, 2026
Conditions: Venous Thrombosis Deep (Limbs); Venous Insufficiency (Chronic)(Peripheral); Varicose Veins Leg; Venous Thrombosis
Interventions: Drug: Apixaban; Drug: Rivaroxaban
Sponsors: Heart, Artery, and Vein Center of Fresno
Completed
July 16, 2026
Conditions: STEMI; No-Reflow Phenomenon; Diabetic Patient
Interventions: Procedure: PCI
Sponsors: Assiut University
Not yet recruiting
July 16, 2026
Conditions: Thymus Neoplasms; Thymic Epithelial Tumor; Thymoma; Thymic Carcinoma
Interventions: Radiation: Hypofractionated Adjuvant Proton Therapy; Radiation: Hypofractionated Adjuvant Photon Radiation Therapy
Sponsors: National Taiwan University Hospital; National Taiwan University
Not yet recruiting
July 15, 2026
Conditions: Atrial Fibrillation (AF); Atrial Fibrillation With Rapid Ventricular Response
Interventions: Drug: Verapamil Hydrochloride; Drug: Metoprolol tartrate
Sponsors: Muhammad Ali Javed
Not yet recruiting
July 15, 2026
Conditions: Rheumatoid Arthritis
Interventions: Drug: Sarilumab, SAR153191 SC; Drug: Sarilumab, SAR153191 IV
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting
July 15, 2026
Conditions: End Stage Chronic Renal Failure; Congestive Heart Failure (CHF); Intravascular Congestion; Fluid Overload
Interventions: Procedure: High-rate ultrafiltration; Procedure: Standard fluid removal
Sponsors: Universidad Autonoma de Nuevo Leon; Hospital Universitario Dr. Jose E. Gonzalez
Recruiting
July 15, 2026
Conditions: Right Heart Failure
Interventions: Device: CorVad Percutaneous Ventricular Assist System
Sponsors: Shenzhen Core Medical Technology CO.,LTD.
Recruiting
July 15, 2026
Conditions: Cardiorenal Metabolic Syndrome; Atherosclerotic Cardiovascular Disease; Chronic Kidney Disease; Coronary Artery Disease; Hypertension; Type 2 Diabetes Mellitus; Peripheral Arterial Disease; Carotid Artery Stenosis
Interventions: Biological: Secukinumab (75 mg); Other: Standard Medical Therapy
Sponsors: Peking University Third Hospital
Not yet recruiting
July 15, 2026
Conditions: Diabetes Mellitus; Balance
Interventions: Behavioral: Experimental: Training Group
Sponsors: Pamukkale University
Not yet recruiting
July 15, 2026
Conditions: Obesity & Overweight; Older Women
Interventions: Behavioral: taekwondo training; Behavioral: multicomponent training; Behavioral: walking exercise
Sponsors: Universidad Católica del Maule; University of Talca
Not yet recruiting
July 15, 2026
Conditions: Heart Failure
Interventions: Behavioral: Nurse-led discharge education
Sponsors: University Hospital, Clermont-Ferrand
Not yet recruiting
July 15, 2026
Conditions: Type 2 Diabetes (T2DM); Metabolic Dysfunction-Associated Steatotic Liver Disease
Sponsors: The Affiliated Hospital of Hangzhou Normal University
Not yet recruiting
July 15, 2026
Conditions: Atrial Fibrillation (AF); Mitral Valve (MV) Regurgitation
Interventions: Device: Left Atrial Appendage Occlusion; Device: Mitral Valve Transcatheter Edge to Edge Repair
Sponsors: EchoPixel, Inc.
Not yet recruiting
July 15, 2026
Conditions: Cardiometabolic Risk Factors
Interventions: Behavioral: RISE-W Micro-Movement Program
Sponsors: Texas Tech University Health Sciences Center
Not yet recruiting
July 15, 2026
Conditions: COPD (Chronic Obstructive Pulmonary Disease); Intersitital Lung Disease
Interventions: Other: MoblO2 controls O2 flow; Other: MoblO2 does not control flow
Sponsors: Minnesota HealthSolutions; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
July 15, 2026
Conditions: HIV Infection; Cardiovascular Diseases (CVD)
Interventions: Drug: Colchicine 0.5 mg; Drug: Placebo
Sponsors: Instituto de Investigación Hospital Universitario La Paz; Instituto de Salud Carlos III
Recruiting
July 15, 2026
Conditions: Healthly Volunteers; Oncologic Disease
Interventions: Other: Experimental: IWT- Interval Walking Training; Other: Exercise training II; Other: Walking
Sponsors: Poznan University of Physical Education
Not yet recruiting
July 15, 2026
Conditions: Tricuspid Regurgitation (TR)
Interventions: Device: Transvenous Tricuspid Valve System implantation + OMT; Drug: OMT
Sponsors: Jenscare Scientific
Active, not recruiting
July 15, 2026
Conditions: Depression and/or Anxiety in the Mild-to-moderate Range; Stress (Psychology); Chronic Medical Illness
Interventions: Behavioral: SanaMente
Sponsors: University of Colorado, Boulder; La Clinica del Pueblo
Recruiting
July 15, 2026
Conditions: Coronary Artery Disease; Valvular Heart Disease; Chronic Thromboembolic Pulmonary Hypertension; Aortic Diseases
Interventions: Other: Physical exercise; Other: Educational program and respiration physiotherapy
Sponsors: Hospital Universitario 12 de Octubre
Completed
July 15, 2026
Conditions: Leptomeningeal Metastasis
Interventions: Device: Calibration Phase; Device: Stepped Wedge Intervention Phase
Sponsors: Case Comprehensive Cancer Center
Not yet recruiting
July 15, 2026
Conditions: Acute Lymphatic Leukemia; Lymphoma
Interventions: Other: QOL assessment, Neuropsychological; Diagnostic Test: Spirometry; Diagnostic Test: DLCO measurement; Diagnostic Test: Echocardioraphy; Diagnostic Test: MRI; Other: Clinical parameters; Diagnostic Test: Blood samples; Diagnostic Test: MSOT
Sponsors: University of Erlangen-Nürnberg Medical School
Recruiting
July 15, 2026
Conditions: Post Tetralogy of Fallot Repair Arrhythmias and Echocardiographic Changes
Interventions: Diagnostic Test: echocardiography , 12-lead ECG and Holter ECG
Sponsors: Sohag University
Not yet recruiting
July 15, 2026
Conditions: ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION; Oral Anticoagulation; Thoracotomy
Interventions: Procedure: Video-assisted thoracoscopic closure of the left atrial appendage using a closure device and discontinuation of treatment if the patient is treated with OAC
Sponsors: Region Skane
Not yet recruiting
July 15, 2026
Conditions: Ischemic Heart Disease
Interventions: Procedure: Fixed Prosthodontic Rehabilitation
Sponsors: Dr. Moaz Mohamed
Completed
July 15, 2026
Conditions: Kidney Failure; Hemodialysis
Interventions: Device: Virtual Reality Glasses; Other: Standard Hemodialysis Care
Sponsors: Ankara Yildirim Beyazıt University
Completed
July 15, 2026
Conditions: Melanoma
Interventions: Drug: Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolocumab, inclisiran)
Sponsors: University of Colorado, Denver
Not yet recruiting
July 15, 2026
Conditions: Pulmonary Arterial Hypertension
Interventions: Procedure: Discontinuation of parenteral prostacyclins analogues or selexipag
Sponsors: University of Alberta
Not yet recruiting
July 15, 2026
Conditions: Chronic Coronary Syndrome; Obstructive Coronary Artery Disease
Interventions: Diagnostic Test: Carotid Ultrasound
Sponsors: London North West Healthcare NHS Trust
Recruiting
July 15, 2026
Conditions: Obesity & Overweight
Interventions: Other: Standard Medical Care with an Obesity Management Medication; Behavioral: Cardiovascular Exercise Training; Behavioral: Resistance Exercise Training; Behavioral: Nutrition Counseling
Sponsors: University of Kansas Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting
July 14, 2026
Conditions: Congenital Heart Disease; Cardiac Surgery
Interventions: Other: Exercise prehabilitation
Sponsors: Liverpool Heart and Chest Hospital NHS Foundation Trust; Liverpool John Moores University
Not yet recruiting
July 14, 2026
Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Interventions: Device: Hip Exoskeleton-Assisted Walking
Sponsors: University of Nebraska
Not yet recruiting
July 14, 2026
Conditions: Breast Cancer; Cardiovascular (CV) Risk; Coronary Artery Calcifications
Interventions: Other: Measuring coronary artery calcifications (Agatston score) using routine radiotherapy planning CT scans and communicating the associated risk of cardiovascular disease to the patient.
Sponsors: UMC Utrecht
Recruiting
July 14, 2026
Conditions: Primary Aldosteronism; Primary Aldosteronism Due to Aldosterone Producing Adenoma
Interventions: Diagnostic Test: 1 mg overnight dexamethasone inhibition test
Sponsors: Peking Union Medical College Hospital
Completed
July 14, 2026
Conditions: Perimenopausal Women; Postmenopausal Female Patients; Cardiovascular (CV) Risk
Interventions: Behavioral: Personal training; Behavioral: App-based physical intervention
Sponsors: Ludwig Boltzmann Institute for Cardiovascular Research
Not yet recruiting
July 14, 2026
Conditions: Cardiovascular Health
Interventions: Other: Longitudinal patient navigation; Other: Standard care
Sponsors: Boston Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
July 14, 2026
Conditions: Urinary Tract Infections; Malnutrition; Inflammation; Stress; Menstrual Hygiene
Interventions: Behavioral: Peer leadership/sensitization + sanitary pads; Other: School infrastructure
Sponsors: University of California Santa Cruz; Paris School of Economics; Laboratoire d'Analyses Médicales Malagasy (LA2M); Consultant Associates; Care International
Enrolling by invitation
July 14, 2026
Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction
Interventions: Behavioral: High-intensity interval training
Sponsors: Peking University Third Hospital; Beijing Municipal Health Commission; National Health Commission of the People's Republic of China
Not yet recruiting
July 14, 2026
Conditions: Infertility (IVF Patients); Clinical Pregnancy After Single Embryo Transfer; Embryo Diagnosis and Selection
Sponsors: Mỹ Đức Hospital; My Duc Phu Nhuan Hospital HCMC, Vietnam
Not yet recruiting
July 14, 2026
Conditions: Nephrectomy / Methods; Intraoperative Hypothermia; Hyperlactatemia
Interventions: Device: Preoperative active warming (prewarming)
Sponsors: Beyzanur Aydoğdu
Recruiting
July 14, 2026
Conditions: Myocardial Infarction
Interventions: Behavioral: Individualized discharge education
Sponsors: Adiyaman Provincial Health Directorate
Not yet recruiting
July 14, 2026
Conditions: Heart Failure; Heart Failure and Reduced Ejection Fraction
Sponsors: Ruijin Hospital Luwan Branch
Recruiting
July 14, 2026
Conditions: Coronary Artery Disease; Coronary Artery Bypass Surgery; Ultrasound
Interventions: Diagnostic Test: Intraoperative Portable Doppler Ultrasound
Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting
July 14, 2026
Conditions: Visual Impairment; Cerebral Visual Impairment; Visual Impairments
Interventions: Behavioral: Adapted Physical Activity Programme
Sponsors: Università degli Studi di Trento
Not yet recruiting
July 14, 2026
Conditions: Heart Failure
Interventions: Diagnostic Test: AutoEF-AI Assessment; Diagnostic Test: Standard Echocardiography (Reference method)
Sponsors: Gérond'if
Not yet recruiting
July 14, 2026
Conditions: Cholesterol (Total and HDL); Exercise
Interventions: Other: Intervention 1: Step-Aerobics Program; Other: Intervention 2: Core Exercise Program
Sponsors: Muğla Sıtkı Koçman University
Completed
July 13, 2026
Conditions: Endocarditis Infective; Endocarditis, Bacterial
Interventions: Drug: Dalbavancin administration; Drug: Standard of Care (Investigator Choice)
Sponsors: Stefan Hagel
Not yet recruiting
July 13, 2026
Conditions: Sleep; Well-being; Mood; Mental Health; Stress (Psychology); Quality of Life; Loneliness
Interventions: Behavioral: Community Park Event Participation
Sponsors: City University of New York, School of Public Health; National Institute on Minority Health and Health Disparities (NIMHD)
Active, not recruiting
July 13, 2026
Conditions: Vascular Ehlers Danlos Syndrome
Interventions: Behavioral: Co-designed exercise-based lifestyle intervention
Sponsors: Sheffield Hallam University
Not yet recruiting
July 13, 2026
Conditions: Interoception; Congenital Heart Disease
Interventions: Other: Interoceptive-Based Group Intervention
Sponsors: University of Glasgow; Golden Jubilee National Hospital
Not yet recruiting
July 13, 2026
Conditions: Diabetic Nephropathy
Interventions: Drug: Naoxintong Capsule; Drug: Placebo
Sponsors: Chen Xiangmei
Not yet recruiting
July 13, 2026
Conditions: Septic Shock and Use of Vasopressin
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
July 13, 2026
Conditions: Cardiovascular-Kidney-Metabolic Syndrome; Atrial Cardiomyopathy; Atrial Fibrillation; Chronic Kidney Disease; Metabolic Syndrome
Sponsors: Grigore T. Popa University of Medicine and Pharmacy
Not yet recruiting
July 13, 2026
Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF)
Interventions: Drug: Vericiguat tablet; Drug: Placebo
Sponsors: National Institute of Cardiovascular Diseases, Pakistan; Horizon Pharmaceuticals
Not yet recruiting
July 13, 2026
Conditions: Overweight, Obesity
Interventions: Drug: ZT002 injection; Drug: ZT002 injection matching placebo
Sponsors: Beijing QL Biopharmaceutical Co.,Ltd
Not yet recruiting
July 13, 2026
Conditions: Resuscitation; Cardiac Arrest (CA)
Interventions: Procedure: Two-Finger (2F) Technique; Procedure: Three-Finger (3F) Technique; Procedure: Heel-of-One-Hand (HOH) Technique; Procedure: Two-Thumb (2T) Technique
Sponsors: Ankara City Hospital Bilkent
Completed
July 13, 2026
Conditions: Coronary Artery Disease; Coronary Artery Bypass Graft (CABG); Surgical Wound Healing
Interventions: Device: Photobiomodulation Therapy; Device: Placebo Laser; Procedure: Conventional Saphenous Vein Harvesting; Procedure: No-Touch Saphenous Vein Harvesting
Sponsors: Federal University of São Paulo
Not yet recruiting
July 13, 2026
Conditions: DM1; Myotonic Dystrophy; Myotonic Dystrophy 1; Myotonic Dystrophy Type 1; Myotonic Dystrophy Type-1; Myotonic Dystrophy, Type 1 (DM1); Myotonic Muscular Dystrophy
Sponsors: Virginia Commonwealth University; Dyne Therapeutics; Myotonic Dystrophy Clinical Research Network (DMCRN)
Recruiting
July 13, 2026
Conditions: Parkinson's Disease (PD); Alzheimer's Disease (AD) and Related Disorders; Older Adults (60 - 85 Years Old)
Interventions: Other: Complex Rhythmic Movement Sequences (CRMS) Sessions
Sponsors: Emory University
Recruiting
July 13, 2026
Conditions: Coronary Artery Stenosis
Interventions: Device: Coronary Laser Atherectomy System; Device: CVX300 Laser System
Sponsors: Shanghai MicroPort Rhythm MedTech Co., Ltd.
Not yet recruiting
July 13, 2026
Conditions: Myocardial Infarction
Interventions: Other: virtual reality glasses
Sponsors: Yuzuncu Yil University
Recruiting
July 13, 2026
Conditions: Heart Failure With Reduced Ejection Fraction; Chronic Heart Failure
Interventions: Drug: Vericiguat; Other: Guideline-directed medical therapy (GDMT) for heart failure
Sponsors: Argyrios Ntalianis
Completed
July 13, 2026
Conditions: Heart Failure Acute; Telemonitoring
Interventions: Device: ECG Monitoting
Sponsors: University of Monastir; Vivalink
Active, not recruiting
July 13, 2026
Conditions: Frail Older Adults
Interventions: Device: AIoT-based Feedback Assistive Strengthening Ergometer
Sponsors: National Cheng Kung University
Completed
July 13, 2026
Conditions: PAH
Interventions: Drug: XBD173
Sponsors: Imperial College London
Enrolling by invitation
July 13, 2026
Conditions: Acute Pancreatitis (AP)
Interventions: Device: Treatment; Other: Control
Sponsors: Arctx Medical, Inc.
Not yet recruiting
July 13, 2026
Conditions: Quality of Life; Health Promotion; Blood Pressure Monitoring, Self
Interventions: Behavioral: Conversations Advancing Resilience and Empowerment (CARE)
Sponsors: University of Texas Rio Grande Valley; National Heart, Lung, and Blood Institute (NHLBI); CAN DO Houston
Recruiting
July 13, 2026
Conditions: PFO; PFO - Patent Foramen Ovale; Cryptogenic Stroke; Patent Foramen Ovale; PFO-associated Stroke
Interventions: Device: Recross P3 Occluder (P3O) System
Sponsors: Recross Cardio, Inc.; SCIRENT Clinical Research and Science d.o.o.
Recruiting
July 13, 2026
Conditions: Non-alcoholic Fatty Liver
Interventions: Other: High intensity interval training; Other: moderate intensity continuous training; Other: Mediterranean diet
Sponsors: Horus University
Not yet recruiting
July 13, 2026
Conditions: Hypertension
Interventions: Drug: Spironolactone (drug); Drug: Candesartan 8mg; Drug: Hydrochlorothiazide (HCTZ) 25 milligrams.; Drug: Amlodipine (5mg)
Sponsors: Ottawa Hospital Research Institute; The Ottawa Hospital
Not yet recruiting
July 13, 2026
Conditions: Analgesia; Perioperative Analgesia; Regional Block Technique
Interventions: Procedure: Parasternal/ Rectus sheath block; Procedure: Erector spinae plane block
Sponsors: National Cancer Institute, Egypt; Saudi German Hospital - Madinah
Not yet recruiting
July 13, 2026
Conditions: Caregiver; Cardiac Disease; Pulmonary Diseases
Interventions: Behavioral: Multimodal Well-being Program
Sponsors: University Health Network, Toronto
Not yet recruiting
July 13, 2026
Conditions: Sepsis; Acute Lung Injury(ALI); Klebsiella Pneumoniae Infection; Hypervirulent Klebsiella Pneumoniae Infection
Sponsors: Southeast University, China
Not yet recruiting
July 13, 2026
Conditions: Decubitus Ulcer
Sponsors: Yuzuncu Yil University
Recruiting
July 13, 2026
Conditions: Sarcopenia
Interventions: Behavioral: Digitally delivered home-based exercise intervention; Behavioral: General physical activity recommendations
Sponsors: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio; Universita di Verona
Recruiting
July 10, 2026
Conditions: Perimenopause; Menopause; Cardiovascular (CV) Risk; Women (Between 30 to 60 Years Old); Cardiovascular Disease Risk Factor; Artificial Intelligence (Al)
Sponsors: Biogipuzkoa Health Research Institute; Fundación Centro de Tecnologías de Interacción Visual y Comunicaciones Vicomtech; Keralty SAS; Particle Summary; iBreve Limited; Magdalena Clinic; Andaluz Health Service; Fundación Pública Andaluza para la gestión de la Investigación en Sevilla; Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos; Asociación Centro de Investigación Cooperativa en Biociencias; Ulma Medical Technologies S Coop; Smartnanosenose Innovation; ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Recruiting
July 10, 2026
Conditions: Chronic Kidney Disease
Interventions: Drug: EC5026 oral tablet
Sponsors: EicOsis Human Health Inc.
Recruiting
July 10, 2026
Conditions: Intracerebral Hemorrhage
Interventions: Drug: Remifentanil and Dexmedetomidine; Drug: Guideline standard care
Sponsors: The Third Affiliated Hospital of Southern Medical University; Shenzhen People's Hospital
Not yet recruiting
July 10, 2026
Conditions: Heart Failure and Reduced Ejection Fraction; Heart Failure Chronic; Heart Failure New York Heart Association Class III; Heart Failure Congestive
Interventions: Device: Implantation of the V-Wave Interatrial shunt; Device: Sham (no implant)
Sponsors: V-Wave Ltd; Johnson & Johnson
Not yet recruiting
July 10, 2026
Conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM); Amyloidosis; Amyloid Cardiomyopathy; Transthyretin Amyloidosis
Interventions: Drug: Acoramidis (AG10) oral tablet
Sponsors: Eidos Therapeutics, a BridgeBio company
Not yet recruiting
July 10, 2026
Conditions: Out-of-hospital Cardiac Arrest (OHCA); Agonal Breathing; Cardiopulmonary Resuscitation Training
Interventions: Behavioral: CPR Refresher and Agonal Breathing Recognition Training
Sponsors: Far Eastern Memorial Hospital; New Taipei City Police Department
Completed
July 10, 2026
Conditions: Atrial Fibrillation (Paroxysmal); Hypertension
Interventions: Device: 24-hour M2VS system multimodal vital sign monitoring; Other: Questionnaire regarding the usability and wearability
Sponsors: University Hospital, Basel, Switzerland; evismo AG; Bern University of Applied Sciences
Not yet recruiting
July 10, 2026
Conditions: Postprandial Glycemic Response; Healthy Adults
Interventions: Behavioral: Walking Without Bot-Fit; Device: Bot-Fit Aqua Mode; Device: Bot-Fit Boost Mode
Sponsors: CHA University; Samsung Electronics
Completed
July 10, 2026
Conditions: Dementia; Weakness in the Exercise of the Family Caregiver Role of Older Adults With Dementia
Interventions: Behavioral: Conectando corazones; Other: Conventional intervention
Sponsors: Universidad de la Sabana
Completed
July 10, 2026
Conditions: Heart Failure - NYHA II - IV; Left Bundle Branch Area Pacing; Left Bundle Branch Block; Intraventricular Conduction Delay; Resynchronization Therapy
Interventions: Device: Physiologic cardiac resynchronization using conduction system pacing and selective LV lead optimization.
Sponsors: University of Pecs; Medical University of Pecs
Not yet recruiting
July 10, 2026
Conditions: Hypertrophic Cardiomyopathy (HCM); Cardiac Myosin Inhibitors
Sponsors: Centro Cardiologico Monzino; Azienda Ospedaliero-Universitaria Careggi; Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI); Azienda Ospedaliera di Padova; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Active, not recruiting
July 10, 2026
Conditions: Thymic Epithelial Tumor
Interventions: Radiation: Postoperative hypo-fractionated radiotherapy
Sponsors: Tianjin Medical University Cancer Institute and Hospital
Recruiting
July 10, 2026
Conditions: Obesity & Overweight; Obesity & Overweight Sleep; Sleep; Metabolic Surgery
Interventions: Procedure: Primary Metabolic Surgery
Sponsors: Catharina Ziekenhuis Eindhoven
Not yet recruiting
July 10, 2026
Conditions: Coronary Artery Disease; CT
Interventions: Procedure: CT-guided PCI; Procedure: Routine PCI
Sponsors: Minneapolis Heart Institute Foundation; HeartFlow, Inc.; Shockwave Medical, Inc.
Not yet recruiting
July 10, 2026
Conditions: Cancer; Sedentary Behaviour
Interventions: Behavioral: Sedentary Behaviour Intervention; Other: Active Control Group
Sponsors: University of Toronto
Recruiting
July 10, 2026
Conditions: Severe Native Calcific Aortic Stenosis; Symptomatic Heart Disease Due to Severe Native Calcific Aortic Stenosis
Interventions: Device: Prospective, single-arm, multi-center study.
Sponsors: Abbott Medical Devices
Not yet recruiting
July 10, 2026
Conditions: STEMI - ST Elevation Myocardial Infarction
Interventions: Device: Sustained thrombectomy; Procedure: Percutaneous Coronary Intervention
Sponsors: Oxford University Hospitals NHS Trust
Recruiting
July 10, 2026
Conditions: Liver Transplantation (LT); End-stage Liver Disease (ESLD)
Interventions: Procedure: Low splanchnic blood volume restrictive fluid management strategy; Procedure: Phlebotomy; Procedure: Optimized cardiac output liberal fluid management strategy
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Institutes of Health Research (CIHR); Canadian Donation and Transplantation Research Program (CDTRP); Canadian Perioperative Anesthesia Clinical Trial (PACT) Group
Recruiting
July 10, 2026
Conditions: STEMI - ST Elevation Myocardial Infarction
Sponsors: Firat University
Recruiting
July 10, 2026
Conditions: Pre-eclampsia; Pregnancy; Post Partum
Sponsors: Icahn School of Medicine at Mount Sinai
Not yet recruiting
July 10, 2026
Conditions: Solid Tumours
Interventions: Drug: GEN1119
Sponsors: Genmab
Not yet recruiting
July 09, 2026
Conditions: Heart Defect, Congenital; Executive Dysfunction
Interventions: Other: E-Fit Intervention
Sponsors: Bea Latal
Not yet recruiting
July 09, 2026
Conditions: Postoperative Cognitive Complications; Open Heart Surgery
Interventions: Device: Cooling Helmet With Cold Water Circulation; Device: Cooling Helmet With Room-Temperature Water Circulation
Sponsors: Indonesia University
Completed
July 09, 2026
Conditions: Critical Illness; Delirium in the Intensive Care Unit; Sleep Quality
Sponsors: Scripps Health
Recruiting
July 09, 2026
Conditions: Heart Failure
Interventions: Drug: Empagliflozin (EMPA); Drug: Standard medical treatment
Sponsors: Ain Shams University
Recruiting
July 09, 2026
Conditions: Diabete Type 2; Aerobic Exercise; Walking
Interventions: Other: Downhill Aerobic Walking Training; Other: Level Aerobic Walking Training; Other: Home exercise session
Sponsors: Acibadem University; Bezmialem Vakif University
Recruiting
July 09, 2026
Conditions: Pain, Procedural (During Sternum Dressing on Infants); Arteriovenous Fistula; Kidney Failure, Chronic
Interventions: Other: Usual Care (Room-Temperature Water Bag); Device: Cryotherapy (Ice Pack); Drug: Lidocaine/Prilocaine Gel
Sponsors: Taipei Medical University
Active, not recruiting
July 09, 2026
Conditions: Cardiovascular Diseases; Coronary Artery Disease; Aging; Atherosclerosis; Myocardial Infarction; Inflammation; Heart Failure
Sponsors: South Tees Hospitals NHS Foundation Trust; Newcastle University
Terminated
July 09, 2026
Conditions: Cystic Fibrosis (CF); Cardiovascular (CV) Risk; Flow-mediated Dilation Evaluation of the Brachial Artery; Pulse Wave Analysis
Sponsors: Liverpool Heart and Chest Hospital NHS Foundation Trust; Asthma and Lung UK; Liverpool John Moores University
Not yet recruiting
July 09, 2026
Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease; Non-alcoholic Fatty Liver Disease NAFLD; Dyslipidemia; Obesity & Overweight
Interventions: Dietary Supplement: Taiwan green propolis capsule; Dietary Supplement: Placebo capsule
Sponsors: Taipei Medical University; Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Recruiting
July 09, 2026
Conditions: Pain; Anxiety; Prostate Biopsy
Interventions: Behavioral: Binaural beats auditory intervention; Behavioral: Classical music auditory intervention; Behavioral: No Music Group
Sponsors: University of Trieste
Completed
July 09, 2026
Conditions: Aneurysm of Aorta, Thoracic; Dissection of Aorta, Thoracic; Trauma
Interventions: Device: Gore® TAG® Thoracic Aortic Branch Stent Graft System
Sponsors: W.L.Gore & Associates; CMIC Co, Ltd. Japan
Not yet recruiting
July 09, 2026
Conditions: Fasting; Dietary Fibre; Gut Microbiome; Metabolism Changes; Overweight , Obesity
Interventions: Dietary Supplement: Fibre Arm; Dietary Supplement: Control Arm
Sponsors: Buchinger Wilhelmi Development & Holding GmbH; Buchinger Wilhelmi Clinic, 88662 Überlingen, Germany; King's College London, Faculty of Life Sciences & Medicine, Department of Nutritional Sciences, London, United Kingdom; Leiden University Medical Center, Department Leiden University Center for Infectious Diseases, 2333ZA, Leiden, Netherlands; TNO, Department Microbiology & Systems Biology, 2333 BE Leiden, Netherlands; Università degli Studi di Milano, Department of Pharmacological and Biomolecular Sciences Rodolfo Paoletti, Milan, Italy; Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Not yet recruiting
July 09, 2026
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Device: Bot-Fit Aqua Mode; Device: Bot-Fit Boost Mode; Behavioral: Non-Assisted Walking
Sponsors: CHA University; Samsung Electronics
Completed
July 09, 2026
Conditions: Cystic Fibrosis Related Diabetes; Cystic Fibrosis (CF); Abnormal Glucose Tolerance
Interventions: Drug: Verapamil Hydrochloride
Sponsors: Rhode Island Hospital
Not yet recruiting
July 09, 2026
Conditions: Ulcerative Colitis (UC)
Interventions: Drug: INT-210 Capsule; Drug: INT-210 Capsule
Sponsors: Innatus Therapeutics (Shanghai) Co., Ltd.
Recruiting
July 09, 2026
Conditions: Atrial Fibrillation (AF); Heart Failure and Reduced Ejection Fraction
Interventions: Drug: wearable device based remote management (GDMT titration for HF, rhythm control and anticoagulation management for AF)
Sponsors: Beijing Anzhen Hospital
Not yet recruiting
July 09, 2026
Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury
Interventions: Other: Transcutaneous spinal electrical stimulation (TSES)
Sponsors: University of Manitoba
Recruiting
July 08, 2026
Conditions: Apnea of Prematurity; Prematurity
Interventions: Other: Maternal odor
Sponsors: Ankara Yildirim Beyazıt University
Completed
July 08, 2026
Conditions: Procedural Pain; Heel Prick; Newborn
Interventions: Device: ShotBlocker; Device: Warm Gel Pack
Sponsors: Marmara University
Completed
July 08, 2026
Conditions: Tiletamine Use Disorder; Substance Use Disorder (SUD); Drug Craving
Interventions: Device: Transcutaneous Auricular Vagus Nerve Stimulation; Device: Sham Stimulation
Sponsors: Shanghai Mental Health Center
Not yet recruiting
July 08, 2026
Conditions: Aortic Stenosis, Severe
Interventions: Device: Transcatheter Heart Valve
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting
July 08, 2026
Conditions: Diabete Type 2
Interventions: Dietary Supplement: Normast® 3 - a food for special medical purposes (FSMP) containing co-micronized palmitoylethanolamide (PEA) with rutin and hydroxytyrosol. It is designed to support the management of diabetic polyneu; Dietary Supplement: Placebo
Sponsors: University of Roma La Sapienza
Recruiting
July 08, 2026
Conditions: Aortic Stenosis
Sponsors: Baker Heart and Diabetes Institute; The Alfred; Monash Medical Centre; St Vincent's Hospital Melbourne; University of Melbourne; Deakin University; La Trobe University; The University of Western Australia; Melbourne Health
Not yet recruiting
July 08, 2026
Conditions: Primiparous Women
Interventions: Drug: Misoprostol; Device: Misoprostol plus Cervical Balloon
Sponsors: Peking University First Hospital
Not yet recruiting
July 08, 2026
Conditions: Cardiovascular Diseases; Cardiopulmonary Arrest; Web-based Gamification
Interventions: Other: web-based gamification application
Sponsors: Karadeniz Technical University
Completed
July 08, 2026
Conditions: Chronic Lymphoid Leukemia
Interventions: Procedure: Cervical, Thoracic, Abdominal, and Pelvic CT Scan
Sponsors: Private Hospital of Confluent, France
Not yet recruiting
July 08, 2026
Conditions: Heart Failure
Sponsors: Medisch Spectrum Twente; Saxion University of Applied Sciences; Deventer Ziekenhuis; University of Twente; Ziekenhuisgroep Twente
Not yet recruiting
July 08, 2026
Conditions: Transthyretin Amyloid Cardiomyopathy
Sponsors: AstraZeneca
Not yet recruiting
July 08, 2026
Conditions: Abdominal Aortic Aneurysm
Interventions: Other: Structured cardiovascular rehabilitation
Sponsors: Medical University Innsbruck
Not yet recruiting
July 08, 2026
Conditions: Ischemic Stroke; Ischemic Stroke, Acute; Transient Ischemic Attack (TIA); Cerebrovascular Disease; Gastrointestinal Complication; Gastrointestinal Bleeding
Interventions: Drug: Tegoprazan 50 mg; Drug: Placebo
Sponsors: Hanyang University Guri Hospital; HK inno.N Corporation
Recruiting
July 08, 2026
Conditions: Postoperative Delirium; Cardiac Surgical Procedures
Sponsors: Southeast University, China
Not yet recruiting
July 08, 2026
Conditions: Systemic Amyloidosis; ATTR Amyloidosis; AL Amyloidosis; Amyloid Cardiomyopathy
Sponsors: Semmelweis University
Recruiting
July 08, 2026
Conditions: Iron Deficiency Anemia (IDA)
Interventions: Drug: Ferric Bepectate IV Injection; Drug: Ferric Carboxymaltose Injection [Ferinject]; Drug: Ferric Carboxymaltose Injection [Injectafer®]
Sponsors: AFT Pharmaceuticals, Ltd.; HungaroTrial
Not yet recruiting
July 08, 2026
Conditions: Osteoarthritis (OA) of the Hip; Osteoarthritis (OA) of the Knee
Interventions: Drug: Extended oral tranexamic acid regimen; Drug: Placebo
Sponsors: Oregon Health and Science University
Not yet recruiting
July 08, 2026
Conditions: Tricuspid Valve Regurgitation; Tricuspid Valve Insufficiency; Tricuspid Valve Disease
Interventions: Device: TruGamma System; Drug: Optimal medical therapy (OMT)
Sponsors: Jiangsu Trulive Medical Co., Ltd
Recruiting
July 07, 2026
Conditions: Heart Failure; Heart Failure and Reduced Ejection Fraction; Heart Failure and Mildly Reduced Ejection Fraction; Muscle Weakness; Inspiratory Muscle Weakness
Interventions: Device: Mechanical Pressure-Threshold IMT Device; Device: PowerBreathe KH2 Electronic IMT Device; Device: Sub-therapeutic Mechanical IMT Device (Sham)
Sponsors: Universidad Nacional Andres Bello
Enrolling by invitation
July 07, 2026
Conditions: Heart Failure With Preserved Ejection Fraction; Iron Deficiency
Interventions: Drug: Ferric derisomaltose; Drug: Placebo (normal saline)
Sponsors: Duke University; National Institutes of Health (NIH); National Institute on Aging (NIA); Kaiser Permanente
Not yet recruiting
July 07, 2026
Conditions: Arrhythmogenic Cardiomyopathy (AC, ARVD/C); Ventricular Tachycardia (VT); Ventricular Fibrillation; ICD; ICD Malfunction; ICD SHOCKS; Ventricular Arrhythmias and Cardiac Arrest; Ventricular Arrhythmia
Sponsors: Policlinico Casilino ASL RMB
Not yet recruiting
July 07, 2026
Conditions: Postpartum Hemorrhage; Uterine Atony; Uterine Atony With Hemorrhage; Elective Cesarean Section
Interventions: Drug: Oxytocin Bolus or Oxytocin Infusion
Sponsors: Stony Brook University
Not yet recruiting
July 07, 2026
Conditions: Anesthesia , Analgesia; Breast Surgery
Interventions: Behavioral: Intraoperative Music
Sponsors: Uludag University
Not yet recruiting
July 07, 2026
Conditions: Hypertension Disorders in Pregnancy; Blood Pressure Measurement in Pregnancy; Inspiratory Strength Training (IST); Pregnancy
Interventions: Other: Exercise at 15% PI max; Other: Exercise at 50% PI max
Sponsors: University of Arizona; Banner University Medical Center
Recruiting
July 07, 2026
Conditions: CHD - Congenital Heart Disease; Single Ventricle Heart Disease
Interventions: Device: vital sign monitoring
Sponsors: Le Bonheur Children's Hospital; The Consortium for Technology & Innovation in Pediatrics (CTIP)
Recruiting
July 07, 2026
Conditions: ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic Lateral Sclerosis; ALS
Interventions: Drug: Foralumab Nasal; Drug: Placebo
Sponsors: Tiziana Life Sciences LTD
Not yet recruiting
July 07, 2026
Conditions: Kawasaki Disease
Interventions: Drug: IVIG; Drug: Aspirin; Drug: Firsekibart
Sponsors: Children's Hospital of Fudan University; Jiangxi Province Children's Hospital
Not yet recruiting
July 07, 2026
Conditions: Cardiogenic Shock; Acute Myocardial Infarction (AMI)
Interventions: Device: Selective C-reactive protein apheresis (PentraSorb®-CRP); Other: Standard of care
Sponsors: Leipzig Heart Science gGmbH; Helios Health Institute GmbH; Heart Center Leipzig at University of Leipzig
Not yet recruiting
July 07, 2026
Conditions: Hypothyroidism; Hypertension; Healthy Adult; Diabete Mellitus; Hyperthyroidism
Interventions: Behavioral: Soleus pushup exercise
Sponsors: King Abdullah University Hospital
Completed
July 07, 2026
Conditions: Heart Failure, Preserved Ejection Fraction
Interventions: Drug: Henggliflozin Combined with Probiotics; Drug: Henggliflozin; Drug: double placebo
Sponsors: The First Affiliated Hospital of Air Force Medicial University
Not yet recruiting
July 07, 2026
Conditions: COPD
Interventions: Procedure: Active Stimulation; Procedure: Sham Stimulation; Procedure: Fan therapy
Sponsors: Johns Hopkins University; Center for Bioengineering Innovation and Design
Not yet recruiting
July 07, 2026
Conditions: Lumbar Spinal Stenosis; Lumbar Degenerative Disease; Obesity; Intraabdominal Hypertension; Intraoperative Blood Loss; Perioperative Complications
Interventions: Other: Intraabdominal Pressure Measurement via Urinary Bladder Catheter; Other: Total Intravenous Anesthesia (TIVA)
Sponsors: Marmara University Pendik Training and Research Hospital
Not yet recruiting
July 07, 2026
Conditions: Heart Failure
Interventions: Drug: Qishen Yiqi Dripping Pills 2 bags; Drug: Qishen Yiqi Dripping Pills placebo 2 bags
Sponsors: Tasly Pharmaceutical Group Co., Ltd
Recruiting
July 07, 2026
Conditions: Severe Tricuspid Valve Regurgitation
Interventions: Device: Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System; Device: Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE TTVR System
Sponsors: Laplace Interventional, Inc
Not yet recruiting
July 07, 2026
Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Drug: INS018_055 tablets; Drug: Placebo
Sponsors: InSilico Medicine Hong Kong Limited
Not yet recruiting
July 07, 2026
Conditions: Chronic Heart Failure
Interventions: Behavioral: CSM-Based Intervention Group; Other: Standard Care (in control arm)
Sponsors: The Third Xiangya Hospital of Central South University
Not yet recruiting
July 07, 2026
Conditions: Takayasu Arteritis; Cardiovascular Diseases
Sponsors: Groupe français d'étude des Maladies Inflammatoires de loeil
Completed
July 07, 2026
Conditions: Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation
Interventions: Device: Catheter Ablation
Sponsors: LUMA Vision Ltd.
Not yet recruiting
July 07, 2026
Conditions: Polycystic Ovary Syndrome (PCOS); Obesity; Infertility, Female
Interventions: Drug: GLP-1 receptor agonist; Drug: Metformin
Sponsors: Peking University Third Hospital
Not yet recruiting
July 07, 2026
Conditions: Financial Exploitation of Older Adults
Interventions: Behavioral: Participants receiving informational self-nudges to improve financial decision-making; Behavioral: Control - Participants receiving informational content on healthy eating and physical activity
Sponsors: The University of Texas Health Science Center, Houston; National Institute on Aging (NIA)
Not yet recruiting
July 07, 2026
Conditions: Cardiovascular (CV) Risk; Behavioral Changes; Gardening; Cooking; Nutrition Education
Interventions: Behavioral: GHH Intervention
Sponsors: Milton S. Hershey Medical Center
Not yet recruiting
July 06, 2026
Conditions: COPD
Interventions: Dietary Supplement: Astaxanthin; Behavioral: Pulmonary rehabilitation training
Sponsors: China-Japan Friendship Hospital
Not yet recruiting
July 06, 2026
Conditions: Pulmonary Embolism Acute
Interventions: Device: Mechanical Thrombectomy
Sponsors: Vicora, Inc.; KCRI
Not yet recruiting
July 06, 2026
Conditions: Obesity
Interventions: Other: Pilates exercise; Other: Intermittent Fasting Diet
Sponsors: Cairo University
Not yet recruiting
July 06, 2026
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Device: AI-assisted antidiabetic drug consultation system; Other: Manual antidiabetic prescribing (without AI)
Sponsors: National Taiwan University Hospital
Not yet recruiting
July 06, 2026
Conditions: Chest Wall Tumor; Breast Cancer; Lung Cancer; Esophageal Cancer; Mediastinal Cancers; Spine Metastases; Spinal Tumor; Thoracic Cancer; Thoracic Neoplasms
Interventions: Drug: Atorvastatin and Lisinopril; Drug: Placebo
Sponsors: UNC Lineberger Comprehensive Cancer Center
Not yet recruiting
July 06, 2026
Conditions: Heart Valve Diseases; Heart Diseases; Cardiovascular Diseases; Tricuspid Valve Disease
Interventions: Device: Edwards TRIFORMIS RESILIA heart valve
Sponsors: Edwards Lifesciences
Not yet recruiting
July 06, 2026
Conditions: Diabetes Mellitus, Type 2; Obesity; Insulin Resistance; Sedentary Behaviors; mHealth; Physical Exercise; Primary Care; Wearable Devices
Interventions: Behavioral: Supervised Exercise Training Program; Behavioral: mHealth Unsupervised Exercise Program (ActiVital App); Device: Wearable Device Monitoring (Fitbit Charge 6); Behavioral: Health Coaching Sessions; Behavioral: Weekly Motivational Text Messages; Other: Usual Medical Care
Sponsors: Escuela Universitaria de Osuna; University of Seville
Not yet recruiting
July 06, 2026
Conditions: Acute Kidney Injury; Acute Interstitial Nephritis
Interventions: Drug: Infliximab; Drug: Prednisone; Drug: prednisone (oral)
Sponsors: Massachusetts General Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
July 06, 2026
Conditions: Hemostasis of Arterial Punctures
Interventions: Device: Air-filled hemostatic band
Sponsors: Wonju Severance Christian Hospital; Whanin Pharmaceutical Company
Not yet recruiting
July 06, 2026
Conditions: Acute Coronary Syndromes; STEMI; NSTEMI; Unstable Angina
Interventions: Drug: Early P2Y12 Inhibitor Monotherapy; Drug: Standard Dual Antiplatelet Therapy
Sponsors: Gyeongsang National University Hospital; Genoss Co., Ltd.; CGBio Inc.; Biotronik SE & Co. KG; Dio Medical
Not yet recruiting
July 06, 2026
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: EXPD-101/FXS7553 Dose 1; Drug: EXPD-101/FXS7553 Dose 2; Drug: Placebo
Sponsors: Expedition Therapeutics, Inc
Recruiting
July 06, 2026
Conditions: Acute Coronary Syndrome
Interventions: Drug: inclisiran; Drug: SOC
Sponsors: Novartis Pharmaceuticals
Not yet recruiting
July 06, 2026
Conditions: Ascites Hepatic
Interventions: Drug: Dapagliflozin
Sponsors: Beni-Suef University
Recruiting
July 06, 2026
Conditions: NSCLC
Interventions: Drug: HS-10504; midazolam
Sponsors: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Not yet recruiting
July 06, 2026
Conditions: Depression; Anxiety; Heart Injuries
Interventions: Diagnostic Test: Diagnostic Test: 18F-AIPFA-1026
Sponsors: Tianjin Medical University; Tianjin Medical University General Hospital
Recruiting
July 06, 2026
Conditions: Acute Aortic Dissection; Surgery (Cardiac); Systemic Immune-inflammation Index; Postoperative Death; Neutrophil to Lymphocyte Ratio; CRP to Albumin Ratio; Prognostic Nutritional Index; Renal Failure Acute Chronic; Platelet to Lymphocyte Ratio
Sponsors: Bursa City Hospital
Completed
July 06, 2026
Conditions: SCAD; ACS (Acute Coronary Syndrome)
Interventions: Drug: Acetylsalicylic acid ASA; Drug: ASA plus Clopidogrel
Sponsors: Universitätsklinikum Hamburg-Eppendorf; National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK; Gesellschaft für Therapieforschung mbH; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK); Cardio-CARE AG, Davos
Not yet recruiting
July 06, 2026
Conditions: Atrial Fibrillation (Prevention of Stroke); Stroke
Interventions: Device: Smartphone-based digital atrial fibrillation screening and management pathway
Sponsors: Medical University Innsbruck; AIT Austrian Institute of Technology GmbH; Medical University of Graz; UMIT Tirol
Recruiting
July 06, 2026
Conditions: ACS (Acute Coronary Syndrome); Hyperlipidemia; Dyslipidemia; Low-Density-Lipoprotein-cholesterol Level
Interventions: Other: Pharmacist-led lipid optimization pathway
Sponsors: University of Alberta
Not yet recruiting
July 06, 2026
Conditions: Septic Shock; Immunocompromised Patients
Sponsors: University of Turin, Italy
Recruiting
July 06, 2026
Conditions: Depression - Major Depressive Disorder; Depression Bipolar; Depression Unipolar
Interventions: Other: Repetitive transcranial magnetic stimulation
Sponsors: Hospital Center Guillaume Régnier
Recruiting
July 06, 2026
Conditions: Heart Failure; Dyspnea
Interventions: Device: Non invasive cardiac assessment with the CardioStory device
Sponsors: CardioStory INC; Eshmoun Clinical Research Center; Sahloul Hospital of Sousse; University Hospital Monastir, Tunis
Recruiting
July 06, 2026
Conditions: Percutaneous Coronary Intervention
Interventions: Behavioral: Nurse-led intervention
Sponsors: Henan University
Completed
July 06, 2026
Conditions: Coronary Artery Disease; Cardiac Autonomic Neuropathy; QT Interval Prolongation
Sponsors: Haseki Training and Research Hospital
Completed
July 06, 2026
Conditions: Heart Failure; Diagnosis; Medically Underserved Area
Interventions: Diagnostic Test: Point-of-care NT-pro-BNP testing
Sponsors: University Hospital, Montpellier
Not yet recruiting
July 06, 2026
Conditions: Hypertension; Coronary Arterial Disease; Percutaneous Coronary Intervention
Interventions: Drug: Losartan + Hydrochlorothiazide; Drug: Amlodipine + Azilsartan
Sponsors: National Medical Research Center for Therapy and Preventive Medicine
Recruiting